ARCALIS is a leading CDMO specializing in mRNA and saRNA vaccines and therapeutics. The company provides end‑to‑end support from early discovery and sequence optimization to CMC development and GMP manufacturing. With flexible R&D services including small‑scale, multi‑product production and advanced LNP formulation capabilities, ARCALIS enables the development of RNA medicines for infectious diseases, rare diseases, oncology, regenerative medicine, and genome editing.
Products